STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC Meeting Abstract

  

Authors:	Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; Shah, N. S.; Ciampricotti, M.; de Stanchina, E.; Poirier, J. T.; Rudin, C. M.; Sen, T.
Abstract Title:	STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
Meeting Title:	113th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	82
Issue:	12 Suppl.
Meeting Dates:	2022 Apr 8-13
Meeting Location:	New Orleans, LA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2022-06-15
Language:	English
ACCESSION:	WOS:000892509504500
PROVIDER:	wos
DOI:	10.1158/1538-7445.AM2022-90
Notes:	Meeting Abstract: 90 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/206126